SCHEMBL14907794

SCHEMBL14907794

COc1ccc(-c2nnc(SCC(=O)O)[nH]2)c(O)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 8/20 0.63
HPGD P15428 2/20 0.44
CYP1A2 P05177 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ALPL P05186 1/20 0.43
ALPG P10696 1/20 0.43
GCGR P47871 1/20 0.43
POLB P06746 2/20 0.42
MAPT P10636 1/20 0.42
FPR1 P21462 1/20 0.42
FPR2 P25090 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14907755 0.92 GRK6 (0.64) GRK6HPGDCYP1A2MEN1ALDH1A1
SCHEMBL17213165 0.87 GRK6 (0.51) GRK6ALPLALPGGCGRMAPT
SCHEMBL14907779 0.87 GRK6 (0.64) GRK6HPGDCYP1A2MEN1ALDH1A1
SCHEMBL14907808 0.87 GRK6 (0.49) GRK6HPGDCYP1A2MEN1ALDH1A1
SCHEMBL12180110 0.86 GRK6 (0.59) GRK6ALDH1A1KMT2AKDM4EHSD17B10
SCHEMBL17213107 0.85 GRK6 (0.56) GRK6HPGDMEN1ALDH1A1KMT2A
SCHEMBL21763920 0.84 GRK6 (0.46) GRK6CYP1A2MEN1KMT2AALPL
SCHEMBL21763938 0.84 GRK6 (0.49) GRK6CYP1A2MEN1KMT2AALPL
SCHEMBL14907725 0.84 GRK6 (0.60) GRK6HPGDMEN1ALDH1A1KMT2A
SCHEMBL21763932 0.82 TDP1 (0.46) GRK6HPGDCYP1A2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3134390-B1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUND MEDICAL EDUCATION & RES (US) 2020-02-26 EP disclosed
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2019-04-09 US disclosed
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2017-02-23 US disclosed
WO-2015164415-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2015-10-29 WO disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
WO-2013063458-A2 INHIBITING G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES GRK6, GRK2, GRK3 GRK6 1/4885HPGD 2617/4885CYP1A2 4876/4885
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides GRK6, GRK2, GRK3 GRK6 1/4885HPGD 2350/4885CYP1A2 4879/4885
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides GRK6, GRK2, GRK3 GRK6 1/4885HPGD 2350/4885CYP1A2 4879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.